This grant supports developing advanced brain stimulation devices for treating mental health disorders, focusing on novel techniques and significant improvements to existing FDA-approved devices.
Funder: National Institutes of Health
Due Dates: February 16, 2027 (New) | March 16, 2027 (Resubmission/revision) | June 16, 2027 (New) | July 16, 2027 (Resubmission/revision) | October 16, 2027 (New) | November 16, 2027 (Resubmission/revision) | January 7, 2028 (Closing)
Funding Amounts: Up to $275,000 in direct costs over two years, with no more than $200,000 in any year
Summary: Supports engineering development of novel brain stimulation devices or significant improvements to existing devices for mental health treatment.
Key Information: Multidisciplinary teams are required; clinical trials and incremental device improvements are not allowed.
The National Institute of Mental Health (NIMH) supports next-generation brain stimulation devices through this NIH R21 exploratory/developmental research opportunity (PAR-25-286). Projects may develop novel invasive or non-invasive devices or significantly enhance FDA-approved or cleared devices through hardware or software innovations. Priorities include greater spatial and temporal precision, deeper stimulation, multi-focal interfaces, and closed-loop approaches.
The program emphasizes engineering development, bench testing, and validation rather than hypothesis-driven studies that simply use devices. It supports shorter, high-risk proof-of-concept projects, including those without preliminary data, and smaller projects closer to final form. Animal studies and limited human testing that does not constitute a clinical trial are allowable when necessary for initial proof of concept. All tools must be designed for eventual human use.